LIQUAMAR Drug Patent Profile
When do Liquamar patents expire, and when can generic versions of Liquamar launch?
Liquamar is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in LIQUAMAR is phenprocoumon. There is one drug master file entry for this compound. Additional details are available on the phenprocoumon profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LIQUAMAR?
- What are the global sales for LIQUAMAR?
- What is Average Wholesale Price for LIQUAMAR?
Summary for LIQUAMAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Patent Applications: | 3,965 |
| DailyMed Link: | LIQUAMAR at DailyMed |
US Patents and Regulatory Information for LIQUAMAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | LIQUAMAR | phenprocoumon | TABLET;ORAL | 011228-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
